TY - JOUR
T1 - The human vaccines project
T2 - A roadmap for cancer vaccine development
AU - Romero, Pedro
AU - Banchereau, Jacques
AU - Bhardwaj, Nina
AU - Cockett, Mark
AU - Disis, Mary L.
AU - Dranoff, Glenn
AU - Gilboa, Eli
AU - Hammond, Scott A.
AU - Hershberg, Robert
AU - Korman, Alan J.
AU - Kvistborg, Pia
AU - Melief, Cornelis
AU - Mellman, Ira
AU - Palucka, A. Karolina
AU - Redchenko, Irina
AU - Robins, Harlan
AU - Sallusto, Federica
AU - Schenkelberg, Theodore
AU - Schoenberger, Stephen
AU - Sosman, Jeffrey
AU - Türeci, Özlem
AU - Van Den Eynde, BenoÎt
AU - Koff, Wayne
AU - Couko, George
N1 - Funding Information:
This work was supported by the Robert Wood Johnson Foundation and Glaxo Smith Kline.
PY - 2016/4/13
Y1 - 2016/4/13
N2 - Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited bymost vaccines tested, but their clinical efficacy remainsmodest.We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.
AB - Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited bymost vaccines tested, but their clinical efficacy remainsmodest.We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.
UR - http://www.scopus.com/inward/record.url?scp=84963801069&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aaf0685
DO - 10.1126/scitranslmed.aaf0685
M3 - Review article
C2 - 27075624
AN - SCOPUS:84963801069
SN - 1946-6234
VL - 8
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 334
M1 - 334ps9
ER -